Most Recent
Escala’s non-compete restraints against ex-partners an ‘overreach’: court
Wealth manager Escada Partners has lost its lawsuit against two former partners who defected to rival LGT Crestone, with a judge finding a five-year non-compete clause was unreasonable.
‘Highly irresponsible’: Peninsula Health must pay $316,000 in junior doctors class action
A judge has ordered Victoria's Peninsula Health to fork over $316,260 in penalties for failing to pay overtime to a junior doctor leading a class action, saying the hospital operator had a “highly irresponsible attitude”.
Atanaskovic Hartnell wins appeal of ‘campaign of denigration’ ruling
An appeals court has set aside a $160,000 judgment against Sydney law firm Atanaskovic Hartnell, overturning a finding that a founding partner engaged in a "campaign of denigration" against a former general manager.
Full Court puts Bed Bath N’ Table’s misleading conduct claims to sleep
In a loss for Bed Bath N' Table, the Full Court has overturned a finding that homewares retailer House engaged in misleading and deceptive conduct by setting up its 'Bed & Bath' stores.
Metcash loses appeal over worker rest breaks
Distribution company Metcash has lost its bid to overturn a decision that found it had to provide employees with a 12-hour break between shifts irrespective of whether the work was ordinary or overtime hours.
ASIC wins case over life insurer’s misleading ‘pre-existing condition’ term
ASIC has won its case against insurer HCF Life over a pre-existing condition term that was likely to mislead the public, but failed to convince the court that it was an unfair contract term. 
Flex commissions class action judge says expert evidence not for his ‘comfort’
Expert evidence is not meant to “provide a judge with comfort”, a judge has found in rejecting evidence from two experts in flex commissions class actions against Westpac and Macquarie.
Coles dodges iFit challenge to Perform powerbar brand
Coles has defeated a trade mark challenge to its Perform brand of sports nutrition products by a sports equipment company.
Bayer’s patents for blockbuster blood thinner Xarelto invalid: court
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
INPEX can cross-examine AkzoNobel’s lawyers over ‘inadequate’ discovery
INPEX has won a bid to cross-examine AkzoNobel's solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project.